Fresenius SE & Co. KGaA
(FSNUF)
Überblick & Kennzahlen
| Preis | 55.9 |
|---|
| Gehandeltes Volumen | 100 |
|---|
| Tageshoch | 51.89 |
|---|
| Tagestief | 51.89 |
|---|
| Eröffnung | 51.89 |
|---|
| Vortagesschluss | 55.9 |
|---|
| Marktkapitalisierung | 31,484,962,816 |
|---|
| Dividendenrendite | 203.00% |
Unternehmensprofil
Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.
Finanzdaten (Jährlich)
|
2024-12-31 00:00:00 |
2023-12-31 00:00:00 |
2022-12-31 00:00:00 |
2021-12-31 00:00:00 |
2020-12-31 00:00:00 |
| Tax Effect Of Unusual Items |
0.000000e+00 |
0.000000e+00 |
0.000000e+00 |
0.000000e+00 |
NaN |
| Tax Rate For Calcs |
3.750000e-01 |
1.500000e-01 |
2.350000e-01 |
2.280000e-01 |
NaN |
| Normalized EBITDA |
3.139000e+09 |
2.692000e+09 |
3.099000e+09 |
6.949000e+09 |
NaN |
| Total Unusual Items |
NaN |
NaN |
NaN |
NaN |
31000000.0 |
| Total Unusual Items Excluding Goodwill |
NaN |
NaN |
NaN |
NaN |
31000000.0 |
| Net Income From Continuing Operation Net Minority Interest |
1.042000e+09 |
1.394000e+09 |
4.770000e+08 |
1.818000e+09 |
NaN |
| Reconciled Depreciation |
1.204000e+09 |
1.400000e+09 |
1.157000e+09 |
2.667000e+09 |
NaN |
| Reconciled Cost Of Revenue |
1.645500e+10 |
1.609600e+10 |
1.612900e+10 |
2.720900e+10 |
NaN |
| EBITDA |
3.139000e+09 |
2.692000e+09 |
3.099000e+09 |
6.949000e+09 |
NaN |
| EBIT |
1.935000e+09 |
1.292000e+09 |
1.942000e+09 |
4.282000e+09 |
NaN |
| Net Interest Income |
-4.320000e+08 |
-3.980000e+08 |
-2.150000e+08 |
-5.060000e+08 |
NaN |
| Interest Expense |
5.470000e+08 |
5.190000e+08 |
3.450000e+08 |
6.300000e+08 |
NaN |
| Interest Income |
1.150000e+08 |
1.210000e+08 |
1.300000e+08 |
1.240000e+08 |
NaN |
| Normalized Income |
1.042000e+09 |
1.394000e+09 |
4.770000e+08 |
1.818000e+09 |
NaN |
| Net Income From Continuing And Discontinued Operation |
4.710000e+08 |
-5.940000e+08 |
1.372000e+09 |
1.818000e+09 |
NaN |
| Total Expenses |
2.005100e+10 |
1.988400e+10 |
1.972000e+10 |
3.336200e+10 |
NaN |
| Total Operating Income As Reported |
1.782000e+09 |
1.183000e+09 |
1.812000e+09 |
4.158000e+09 |
NaN |
| Diluted Average Shares |
5.632373e+08 |
5.632373e+08 |
5.612643e+08 |
5.581563e+08 |
NaN |
| Basic Average Shares |
5.632373e+08 |
5.632373e+08 |
5.612643e+08 |
5.580619e+08 |
NaN |
| Diluted EPS |
8.400000e-01 |
-1.050000e+00 |
2.440000e+00 |
3.260000e+00 |
NaN |
| Basic EPS |
8.400000e-01 |
-1.050000e+00 |
2.440000e+00 |
3.260000e+00 |
NaN |
| Diluted NI Availto Com Stockholders |
4.710000e+08 |
-5.940000e+08 |
1.372000e+09 |
1.818000e+09 |
NaN |
| Average Dilution Earnings |
NaN |
NaN |
0.000000e+00 |
0.000000e+00 |
0.0 |
| Net Income Common Stockholders |
4.710000e+08 |
-5.940000e+08 |
1.372000e+09 |
1.818000e+09 |
NaN |
| Otherunder Preferred Stock Dividend |
0.000000e+00 |
0.000000e+00 |
0.000000e+00 |
0.000000e+00 |
NaN |
| Net Income |
4.710000e+08 |
-5.940000e+08 |
1.372000e+09 |
1.818000e+09 |
NaN |
| Minority Interests |
1.750000e+08 |
1.106000e+09 |
-7.450000e+08 |
-1.001000e+09 |
NaN |
| Net Income Including Noncontrolling Interests |
2.960000e+08 |
-1.700000e+09 |
2.117000e+09 |
2.819000e+09 |
NaN |
| Net Income Discontinuous Operations |
-5.710000e+08 |
-1.988000e+09 |
8.950000e+08 |
NaN |
NaN |
| Net Income Continuous Operations |
8.670000e+08 |
2.880000e+08 |
1.222000e+09 |
2.819000e+09 |
NaN |
| Tax Provision |
5.210000e+08 |
4.850000e+08 |
3.750000e+08 |
8.330000e+08 |
NaN |
| Pretax Income |
1.388000e+09 |
7.730000e+08 |
1.597000e+09 |
3.652000e+09 |
NaN |
| Special Income Charges |
NaN |
NaN |
NaN |
NaN |
31000000.0 |
| Other Special Charges |
NaN |
NaN |
NaN |
NaN |
-31000000.0 |
| Net Non Operating Interest Income Expense |
-4.320000e+08 |
-3.980000e+08 |
-2.150000e+08 |
-5.060000e+08 |
NaN |
| Interest Expense Non Operating |
5.470000e+08 |
5.190000e+08 |
3.450000e+08 |
6.300000e+08 |
NaN |
| Interest Income Non Operating |
1.150000e+08 |
1.210000e+08 |
1.300000e+08 |
1.240000e+08 |
NaN |
| Operating Income |
1.782000e+09 |
1.183000e+09 |
1.812000e+09 |
4.158000e+09 |
NaN |
| Operating Expense |
3.596000e+09 |
3.788000e+09 |
3.591000e+09 |
6.153000e+09 |
NaN |
| Other Operating Expenses |
3.290000e+08 |
5.170000e+08 |
2.110000e+08 |
2.760000e+08 |
NaN |
| Research And Development |
6.410000e+08 |
6.610000e+08 |
6.390000e+08 |
8.050000e+08 |
NaN |
| Selling General And Administration |
2.919000e+09 |
3.027000e+09 |
3.094000e+09 |
5.453000e+09 |
NaN |
| Selling And Marketing Expense |
6.970000e+08 |
7.420000e+08 |
7.460000e+08 |
1.059000e+09 |
NaN |
| General And Administrative Expense |
2.222000e+09 |
2.285000e+09 |
2.348000e+09 |
4.394000e+09 |
NaN |
| Gross Profit |
5.378000e+09 |
4.971000e+09 |
5.403000e+09 |
1.031100e+10 |
NaN |
| Cost Of Revenue |
1.645500e+10 |
1.609600e+10 |
1.612900e+10 |
2.720900e+10 |
NaN |
| Total Revenue |
2.183300e+10 |
2.106700e+10 |
2.153200e+10 |
3.752000e+10 |
NaN |
| Operating Revenue |
2.183300e+10 |
2.106700e+10 |
2.153200e+10 |
3.752000e+10 |
NaN |
Haupteigner
| Breakdown |
Value |
| insidersPercentHeld |
0.27000 |
| institutionsPercentHeld |
0.46695 |
| institutionsFloatPercentHeld |
0.63965 |
| institutionsCount |
550.00000 |
Letzte Analystenempfehlungen
Keine Empfehlungen verfügbar.